Patents for A61P 33 - Antiparasitic agents (21,787)
02/2000
02/24/2000WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders
02/24/2000WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
02/24/2000WO2000000213B1 Compositions and methods for killing or repelling insects
02/24/2000CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof
02/24/2000CA2339970A1 Nematicidal pyrazoles
02/24/2000CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders
02/24/2000CA2301201A1 Method of inhibiting cathepsin k
02/24/2000CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
02/23/2000CN1245168A Amino quinoline derivatives
02/23/2000CN1049557C Method for controlling parasitic nematodes of plant with pyrrolidine compound
02/22/2000US6028096 Parasiticidal pyrazoles
02/22/2000US6028090 Adhesion receptor antagonists III
02/22/2000US6027934 Nucleic acid and vectors encoding an immunodominant fragment of a unique protein antigen originally derived from trypanosoma brucei rhodesiense organisms can induce immunoprotection such as against trypanosomes, leishmania
02/17/2000WO2000008031A1 Novel phospholipids with unsaturated alkyl and acyl chains
02/17/2000WO1999063824A8 Control of parasitic infestations in farmed and wild fish
02/17/2000WO1999055316A8 Kinase obtained from leishmania
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2338385A1 Human receptor-associated proteins
02/16/2000EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
02/16/2000EP0979080A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
02/16/2000CN1244532A 3,6-aldehyde acetal and enol ether large ring lactone vitamine
02/15/2000US6025350 C-4" substituted macrolide antibiotics
02/15/2000US6024966 Gene encoding protein antigens of plasmodium falciparum and uses therefor
02/15/2000CA1340897C 1,2,4-trioxane derivatives
02/10/2000WO2000006730A2 Human cytoskeletal proteins
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000DE19835611A1 Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten Novel synthetic phospholipids with unsaturated alkyl and acyl chains
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/09/2000EP0977862A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
02/09/2000EP0977774A1 Antipathogenic synthetic peptides and compositions comprising them
02/09/2000EP0977725A1 New fatty acid derivatives
02/09/2000EP0977562A1 Methods and compositions for delivery of taxanes
02/09/2000EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
02/09/2000CN1244126A Universal T-cell epitopes for anti-malarial vaccines
02/08/2000US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine
02/08/2000US6022546 Toxoplasma gondii antigens, the preparation thereof and the use thereof
02/03/2000WO2000005371A1 Keratinocyte derived interferon
02/03/2000WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb
02/03/2000WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
02/03/2000CA2335655A1 Keratinocyte derived interferon
02/02/2000EP0975680A1 Interactive system for substance presentation and elimination
02/02/2000EP0975632A1 Alkaloid halide salts of swainsonine and methods of use
02/02/2000EP0975225A1 Fibrocyte-based cellular therapy formulations
02/02/2000EP0777683B1 Antiprotozoal cyclic tetrapeptides
02/02/2000EP0674516B1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
02/01/2000US6020510 Cytoprotective compounds
02/01/2000US6020381 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of protozoan infections
02/01/2000US6019986 Parasiticidal pyrazoles
02/01/2000US6019985 Immunostimulation methods for providing disease protection in poultry
02/01/2000CA2161703C Pour-on formulations containing polymeric material, glycols and glycerides
01/2000
01/27/2000WO2000004031A1 Phosphorous organic compounds and their use
01/27/2000WO2000004024A1 Antiparasitic artemisinin derivatives (endoperoxides)
01/27/2000WO2000004022A1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
01/27/2000CA2337351A1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
01/27/2000CA2337119A1 Antiparasitic artemisinin derivatives (endoperoxides)
01/27/2000CA2336143A1 Aminoalkylphosphonic acid derivatives and their use in treating infections
01/26/2000EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/26/2000EP0973756A1 Thiodepsipeptides for combating endoparasites and a method for producing the same
01/26/2000CN1242802A Notch protein and their ligands
01/25/2000US6018080 Atovaquone pharmaceutical compositions
01/25/2000US6017922 Thermally stable trimetrexates and processes for producing the same
01/25/2000US6017757 A homogenous cell population of parasitic cells obtained by in-vitro culturing of differentiated intestinal cells of a nematode; therapy and prevention of parasitic infections in animals
01/25/2000US6017538 Plasmodium falciparum antigens inducing protective antibodies
01/20/2000WO1999052515A3 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
01/20/2000DE19831985A1 New tetrafluoroethylenedioxy-benzimidazole derivatives useful as antiparasitic agents, especially for treating coccidiosis in poultry
01/19/2000EP0971953A1 Vp22 proteins and uses thereof
01/19/2000EP0971721A1 Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease
01/19/2000EP0971720A1 Use of bacterial cell wall extracts for treating topical disorders and wounds
01/19/2000EP0971589A1 Process and means for the eradication of ticks in the habitats of small mammals
01/19/2000EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
01/19/2000EP0701440B1 Tri(platinum) complexes
01/19/2000CN1241908A Endoparasiticidal and ectoparasiticidal agents
01/18/2000US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
01/18/2000US6015578 Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators
01/13/2000WO2000001347A2 Formulations for controlling human lice
01/12/2000EP0970190A1 Isolated viable parasite intestinal cells
01/12/2000CN1241191A Counterparts of camptothecin, their application as medicine and pharmaceutical compositions contg. them
01/11/2000US6013837 Aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
01/11/2000US6013629 Anti-protozoan methods and materials
01/11/2000US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions
01/11/2000US6013268 Methods for enhancement of protective immune responses
01/06/2000WO2000000213A1 Compositions and methods for killing or repelling insects
01/05/2000EP0968706A2 Formulations for controlling human lice containing spynosin
01/05/2000EP0726902B1 Polycyclic antiparasitic agents, process and strain for their preparation and their use
01/05/2000EP0633894B1 Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification
12/1999
12/30/1999DE19828322A1 New coccidiocide vaccine comprises inactivated, immunogenic sporocytes of pathogenic Eimeria species
12/30/1999DE19828047A1 New sulfonyl-substituted cyclooctadepsipeptide derivatives useful for prevention and treatment of helminth infection
12/29/1999WO1999067281A1 Substituted cyclooctadepsipeptides
12/29/1999WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
12/29/1999WO1999066953A2 Coccidiosis vaccine, method for the production thereof, and the use thereof
12/29/1999WO1999057125A3 Hygromycin a derivatives
12/29/1999EP0967206A1 Derivatives of N-phenylpyrazoles
12/29/1999EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD
12/29/1999EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/29/1999EP0966285A1 Use of (+)mefloquine for the treatment of malaria
12/29/1999EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof
12/29/1999CA2332122A1 Substituted cyclooctadepsipeptides
12/28/1999US6008247 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents